Skip to main content

Sigma-Aldrich Inks Peptide Distribution Deal

NEW YORK (GenomeWeb News) – Sigma-Aldrich today said that CPC Scientific will sell the firm's PEPscreen custom peptide libraries to life science researchers and pharmaceutical companies in North America.

San Jose, Calif.-based CPC specializes in peptide synthesis and supplying GMP peptides to researchers.

Sigma said that it has developed a synthesis platform that enables high-throughput production of milligram quantities of peptides, which are ideal for making custom peptides that would be used in drug discovery efforts.

"CPC's close association with the pharmaceutical and biotechnology industry provides great opportunities for Sigma-Aldrich to further engage drug discovery researchers," said Stacey Hoge, senior product manager for Sigma-Aldrich, in a statement.

Terms of the deal were not disclosed.

In a separate announcement today, Sigma said that its SAFC Pharma business segment had commenced operations at its new 7,000-square-feet laboratory in Carlsbad, Calif. The new complex includes a dedicated PCR facility, a tissue culture lab, and a scientific team focused on quality control process development, assay development, and validation.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.